BDBM525279 US11173137, Compound FA26::US11173137, Compound AK3-98B
SMILES Cc1ccc(Cl)c2[nH]c3c(ccc(F)c3c12)C([O-])=O
InChI Key InChIKey=HPPILTSFNNPAGH-UHFFFAOYSA-M
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 14 hits for monomerid = 525279
TargetAlpha-2A adrenergic receptor(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: 3.00E+3nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 6(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 5(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1A(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M1(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 8(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M5(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 1(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetMetabotropic glutamate receptor 4(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataKi: >1.00E+4nMAssay Description:Two exemplary compounds, FA44 and FA26, were screened against a panel of CNS receptors, transporters, and ion channels to examine specificity for CLC...More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: >6.90E+4nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride intracellular channel protein 1(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: >3.00E+7nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair
TargetChloride channel protein 2(Human)
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 200nMAssay Description:CLC-2 activity using cell-free assays, e.g., binding assays; with purified enzymes.More data for this Ligand-Target Pair